Pilot Study Characterizing the Pharmacokinetic Profile of a Novel Encapsulated Caffeine Beverage in the Fed and Fasted States
Clinical trial NCT05266248 · COMPLETED
Trial details
- NCT number
- NCT05266248
- Sponsor
- PepsiCo Global R&D
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-25
- Primary completion
- 2022-02-03
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.